세계의 진해제 시장 : 동향, 예측, 경쟁 분석(-2030년)

Cough Suppressant Trends and Forecast

The future of the global cough suppressant market looks promising with opportunities in the hospital, retail pharmacy, drug store, and online pharmacy markets. The global cough suppressant market is expected to grow with a CAGR of 4.3% from 2024 to 2030. The major drivers for this market are rising prevalence of respiratory disorders, demand for cough suppressants increases as a result of growing air pollution levels irritating the respiratory system and causing coughing, and increasing demand for convenient and readily available treatments.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Cough Suppressant by Segment

The study includes a forecast for the global cough suppressant by type, drug type, form, distribution channel, and region.

Cough Suppressant Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Dry Cough
• Wet Cough

Cough Suppressant Market by Drug Type [Shipment Analysis by Value from 2018 to 2030]:

• Dextromethorphan
• Codeine
• Noscapine
• Levodropropizine
• Others

Cough Suppressant Market by Form [Shipment Analysis by Value from 2018 to 2030]:

• Solid
• Liquid
• Spray

Cough Suppressant Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Retail Pharmacies
• Drug Stores
• Online Pharmacies
• Others

Cough Suppressant Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Cough Suppressant Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cough suppressant companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cough suppressant companies profiled in this report include-

• Abbott Laboratories
• Acella Pharmaceuticals
• GlaxoSmithKline
• Johnson & Johnson Services
• Merck
• Novartis International
• Pfizer
• Procter & Gamble
• Reckitt Benckiser Group
• Sanofi

Cough Suppressant Market Insights

Lucintel forecasts that dry cough will remain larger segment over the forecast period due to remedies for dry coughs are becoming more popular as upper throat infections are causing more and more irritation and tickling.

Within this market, retail pharmacy will remain the largest segment.

North America will remain the largest region over the forecast period due to growing cases of bacterial infection of the throat.

Features of the Global Cough Suppressant Market

Market Size Estimates: Cough suppressant market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cough suppressant market size by type, drug type, form, distribution channel, and region in terms of value ($B).

Regional Analysis: Cough suppressant market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, drug type, form, distribution channel, and regions for the cough suppressant market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cough suppressant market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for cough suppressant market?

Answer: The global cough suppressant market is expected to grow with a CAGR of 4.3% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the cough suppressant market?

Answer: The major drivers for this market are rising prevalence of respiratory disorders, demand for cough suppressants increases as a result of growing air pollution levels irritating the respiratory system and causing coughing, and increasing demand for convenient and readily available treatments.

Q3. What are the major segments for cough suppressant market?

Answer: The future of the global cough suppressant market looks promising with opportunities in the hospital, retail pharmacy, drug store, and online pharmacy markets.

Q4. Who are the key cough suppressant market companies?

Answer: Some of the key cough suppressant companies are as follows:

• Abbott Laboratories
• Acella Pharmaceuticals
• GlaxoSmithKline
• Johnson & Johnson Services
• Merck
• Novartis International
• Pfizer
• Procter & Gamble
• Reckitt Benckiser Group
• Sanofi

Q5. Which cough suppressant market segment will be the largest in future?

Answer: Lucintel forecasts that dry cough will remain larger segment over the forecast period due to remedies for dry coughs are becoming more popular as upper throat infections are causing more and more irritation and tickling.

Q6. In cough suppressant market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to growing cases of bacterial infection of the throat.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the cough suppressant market by type (dry cough and wet cough), drug type (dextromethorphan, codeine, noscapine, levodropropizine, and others), form (solid, liquid, and spray), distribution channel (hospitals, retail pharmacies, drug stores, online pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cough Suppressant Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Cough Suppressant Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Cough Suppressant Market by Type
  • 3.3.1: Dry Cough
  • 3.3.2: Wet Cough
• 3.4: Global Cough Suppressant Market by Drug Type
  • 3.4.1: Dextromethorphan
  • 3.4.2: Codeine
  • 3.4.3: Noscapine
  • 3.4.4: Levodropropizine
  • 3.4.5: Others
• 3.5: Global Cough Suppressant Market by Form
  • 3.5.1: Solid
  • 3.5.2: Liquid
  • 3.5.3: Spray
• 3.6: Global Cough Suppressant Market by Distribution Channel
  • 3.6.1: Hospitals
  • 3.6.2: Retail Pharmacies
  • 3.6.3: Drug Stores
  • 3.6.4: Online Pharmacies
  • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Cough Suppressant Market by Region
• 4.2: North American Cough Suppressant Market
  • 4.2.1: North American Cough Suppressant Market by Type: Dry Cough and Wet Cough
  • 4.2.2: North American Cough Suppressant Market by Distribution Channel: Hospitals, Retail Pharmacies, Drug Stores, Online Pharmacies, and Others
• 4.3: European Cough Suppressant Market
  • 4.3.1: European Cough Suppressant Market by Type: Dry Cough and Wet Cough
  • 4.3.2: European Cough Suppressant Market by Distribution Channel: Hospitals, Retail Pharmacies, Drug Stores, Online Pharmacies, and Others
• 4.4: APAC Cough Suppressant Market
  • 4.4.1: APAC Cough Suppressant Market by Type: Dry Cough and Wet Cough
  • 4.4.2: APAC Cough Suppressant Market by Distribution Channel: Hospitals, Retail Pharmacies, Drug Stores, Online Pharmacies, and Others
• 4.5: ROW Cough Suppressant Market
  • 4.5.1: ROW Cough Suppressant Market by Type: Dry Cough and Wet Cough
  • 4.5.2: ROW Cough Suppressant Market by Distribution Channel: Hospitals, Retail Pharmacies, Drug Stores, Online Pharmacies, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Cough Suppressant Market by Type
  • 6.1.2: Growth Opportunities for the Global Cough Suppressant Market by Drug Type
  • 6.1.3: Growth Opportunities for the Global Cough Suppressant Market by Form
  • 6.1.4: Growth Opportunities for the Global Cough Suppressant Market by Distribution Channel
  • 6.1.5: Growth Opportunities for the Global Cough Suppressant Market by Region
• 6.2: Emerging Trends in the Global Cough Suppressant Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Cough Suppressant Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cough Suppressant Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abbott Laboratories
• 7.2: Acella Pharmaceuticals
• 7.3: GlaxoSmithKline
• 7.4: Johnson & Johnson Services
• 7.5: Merck
• 7.6: Novartis International
• 7.7: Pfizer
• 7.8: Procter & Gamble
• 7.9: Reckitt Benckiser Group
• 7.10: Sanofi